The elastomeric infusion pumps market is estimated to be valued at USD 1,257.8 Mn in 2025, exhibiting a compound annual growth rate (CAGR) of 9.4% from 2025 to 2032.
To learn more about this report, Download Free Sample
Elastomeric infusion pumps, also known as disposable balloon pumps, are used to administer intravenous (IV) drugs such as local anesthetics, antibiotics, and anti-neoplastic. These non-electronic, non-gravity driven devices are used in single infusions. Elastomeric infusion pumps contain a stretchable balloon reservoir that is filled with a drug and pressure from the elastic walls drives fluid delivery with relatively consistent pressure until it reaches near the end of the infusion.
However, the costs of elastomeric infusion pumps keep fluctuating depending on the type of the pumps which is restraining the growth of the market.
|
Current Events |
Description and its impact |
|
Healthcare Infrastructure Expansion in Emerging Markets |
|
|
Regulatory Landscape and Compliance Requirements |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The expanding geriatric population is significantly driving the demand for convenient pain management solutions, which in turn is propelling the growth of the elastomeric infusion pumps market. As people age, they often experience chronic pain stemming from conditions such as arthritis, neuropathy, cancer, and post-surgical recovery requirements. Elastomeric infusion pumps, offering a portable, easy-to-use, and non-electronic method for continuous drug delivery, provide a valuable alternative to traditional pain management techniques that can be invasive or require frequent hospital visits.
For instance, according to the World Health Organization, between 2015 and 2050, the percent of the world's population over and above 60 years will nearly double from 12% to 22%. This demographic shift underscores the critical need for innovative and accessible pain management technologies like elastomeric infusion pumps to improve quality of life for the aging population.
In terms of treatment, the pain management segment is expected to contribute 37.6% share of the market in 2025, owing to strong patient preference for outpatient pain control, and the growing emphasis on enhanced recovery protocols in surgical procedures across the globe.
The effective use of elastomeric infusion pumps in managing acute and chronic pain has become increasingly embraced in hospitals, ambulatory surgical centers, and home healthcare settings. For example, numerous healthcare institutions globally utilize elastomeric pumps following orthopedic surgeries such as total knee and hip arthroplasties, where continuous delivery of local anesthetics is critical to controlling postoperative pain without resorting to systemic opioid administration.
Artificial Intelligence (AI) is revolutionizing healthcare technologies with its potential to enhance precision, efficiency, and patient outcomes. Within the elastomeric infusion pumps market—a sector focused on devices that deliver controlled doses of medication through flexible, portable systems—AI is driving significant innovation.
To learn more about this report, Download Free Sample
North America is expected to be the largest market for elastomeric infusion pumps during the forecast period, accounting for over 41.80% of the market share in 2025. The leading segment within North America’s elastomeric infusion pumps market is the small-volume elastomeric pumps, primarily driven by their extensive use in ambulatory infusion therapies such as pain management, antibiotic administration, and chemotherapy. These pumps offer advantages including simplicity, portability, and ease of operation without the need for electronic components, which makes them highly favored across various care settings, especially outpatient care and home healthcare.
For instance, in January 2025, a B. Braun EasyPump elastomeric infusion device was reported to have malfunctioned due to over-infusion, according to a filing in the U.S. FDA’s MAUDE database. The event, which did not result in patient injury, underscores the importance of post-market monitoring for infusion technologies commonly used in home and outpatient care settings. The device continued to operate within performance specifications, according to the report.
The U.S. leads the global elastomeric infusion pumps market, driven by its robust home healthcare infrastructure and rising preference for outpatient treatment. Increasing chronic disease incidence, particularly cancer and post-operative pain, has created high demand for portable, non-electronic infusion systems. Additionally, favorable reimbursement frameworks and the U.S. FDA’s streamlined approval process for Class II devices have accelerated adoption across ambulatory care settings.
Canada’s market growth is fueled by its aging population and increasing healthcare decentralization. The national push toward cost-effective care delivery outside of hospitals has led to greater use of elastomeric pumps in home infusion programs. Provincial health systems have embraced these devices for antibiotic therapy and palliative care, especially in rural and underserved regions, where hospital access may be limited.
Germany is a key driver within Europe due to its advanced healthcare system and emphasis on quality-of-life treatments. Elastomeric pumps are widely used in post-surgical recovery and oncology, supported by strong physician acceptance and insurance coverage. Ongoing shifts toward outpatient care and the use of infusion devices in pain clinics are creating steady demand for these non-electronic delivery solutions.
Japan's elastomeric infusion pumps market is propelled by its super-aged society and a strong tradition of home-based care. With one of the highest elderly population ratios globally, there’s increasing reliance on infusion therapy for chronic conditions. The government’s focus on reducing hospital stays and promoting long-term home care has created a supportive environment for portable infusion technologies like elastomeric pumps.
|
Region |
Price Range |
|
North America |
USD 40 – USD 130 |
|
Europe |
USD 35 – USD 120 |
|
Asia-Pacific |
USD 25 – USD 90 |
|
Latin America |
USD 30 – USD 85 |
|
Middle East & Africa |
USD 30 – USD 80 |
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
|
Macro-Economic Factors |
Micro-Economic Factors |
|
Aging Population and Chronic Disease Prevalence: Global demographic shifts, particularly rising geriatric populations and chronic disease rates, drive demand for home healthcare solutions. For example, in the U.S., elastomeric pumps are increasingly adopted for administering pain management drugs and chemotherapy to elderly patients with limited mobility. |
Competitive Landscape and Market Structure: The market remains oligopolistic, dominated by players like B. Braun SE and Terumo Corporation. Example: Zydus Cadila’s investment in AI-integrated pumps improves infusion accuracy, reducing dosing errors in chemotherapy. |
|
Regulatory and Policy Environments: Region-specific regulations influence product availability. For example, the FDA in the U.S. and CE mark in Europe require strict compliance, limiting market entry for new manufacturers. Established players like Baxter and Fresenius Kabi leverage regulatory expertise to maintain dominance. |
Pricing Strategies and Consumer Behavior:
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 1,257.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.4% | 2032 Value Projection: | USD 2,359.03 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
B. Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, Baxter International Inc., Halyard Health, and Nipro Corporation |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
*Definition: The elastomeric infusion pumps market refers to the global industry involved in the production, distribution, and use of non-electronic, disposable infusion devices that deliver controlled and continuous medication—such as pain relievers, antibiotics, or chemotherapy—using the pressure of an elastic balloon reservoir. These pumps are widely used in ambulatory care, home healthcare, and post-operative settings due to their portability, simplicity, and low risk of mechanical failure.
Share
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
